. Author manuscript; available in PMC: 2015 Aug 27.

Published in final edited form as: Clin Exp Pharmacol Physiol. 2011 Aug;38(8):501–509. doi: 10.1111/j.1440-1681.2011.05537.x

Table 1.

Primers used in the present study

Gene	Accession no.	Primers (5′–3′)	Amplicon size (bp)
LIFR	NM_031048	Forward: TCCATGCACCCCAAATCACGTCGAA Reverse: CGCCTGGTTCTCGGGGTCTGTCTCA	133
LIF	NM_022196	Forward: TGCCCCTACTGCTCATTCTG Reverse: GGTTCCCCTTGAGCTGTGTA	193
STAT3	NM_012747	Forward: AGGTGTACCACCAAGGTCTCA Reverse: CCAATCGGAGGCTTAGTGAA	166
GAPDH	NM_017008	Forward: ATCACTGCCACTCAGAAGACT Reverse: CATGCCAGTGAGCTTCCCGTT	153

LIF, leukaemia inhibitory factor; LIFR, LIF receptor; STAT3, signal transducer and activator of transcription 3.